ADMA Biologics Says FDA Approves ASCENIV Supplemental BLA
4/5 13:29
(RTTNews) - Biopharmaceutical company ADMA Biologics, Inc. (ADMA) announced Monday the U.S. Food and Drug Administration (FDA) has approved the Company's supplemental Biologics License Application (BLA) submitted under section 351(a) of the Public Health Service Act for ASCENIV....